NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-007-1999-2-US-09 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers US CON 13/676,382 9284610 Expired PDF
NIDCR E-032-2013-0-PCT-02 METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS PCT PCT PCT/US2012/064909 Expired
NIAID E-241-2011-1-PCT-02 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES PCT PCT COMB PCT/US2012/064788 Expired
NIAID E-241-2011-1-US-01 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES US CIP 13/675,447 Abandoned
NHLBI E-011-2010-0-US-04 Compositions And Methods For Preventing Or Treating A Human Parvovirus Infection US National Stage 13/578,577 Abandoned
NIAID E-241-2011-0-EP-02 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES EP ORD 12790771.5 Abandoned
NCI E-221-2012-0-US-01 Synallele Libraries US 61/725,807 Abandoned
NIAAA E-282-2012-0-US-01 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US 61/725,949 Abandoned
NIDCD E-222-2003-1-US-07 Variants Of Human Taste Receptor Genes US DIV 13/674,637 9783590 Issued PDF
NHLBI E-248-2011-0-PCT-02 Methods for Detecting Infectious Agents and A Novel Virus Detected Thereby PCT PCT PCT/US2012/064668 Expired
NCI E-013-2012-0-PCT-02 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY PCT PCT PCT/US2012/064693 Expired
NIAID E-014-2013-0-US-01 NOVEL ASSAY FOR CELLS EXPRESSING INFLUENZA VIRUS-SPECIFIC ANTIBODIES US 61/725,884 Abandoned
NCI E-013-2012-0-CA-03 GENE EXPRESSION SIGNATURES OF NEOPLASM RESPONSIVENESS TO THERAPY CA National Stage 2854665 Abandoned
NIAID E-281-2011-0-PCT-02 Synthetic Catalase/Superoxide Dismutase Mimetics For Viral Infections PCT PCT PCT/US2012/064383 Expired
NIAID E-061-2012-0-PCT-02 Assay For Diabetes-Associated Autoantibodies PCT PCT PCT/US2012/064373 Expired
NIAAA E-061-2010-0-HK-08 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE HK National Stage 12111349.1 Abandoned
NIAID E-253-2011-3-IN-04 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE IN National Stage 3678/DELNP/2014 Issued
NIAID E-253-2011-3-BR-07 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE BR National Stage BR112014010823-4 Issued
NIAID E-253-2011-3-GB-12 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE GB EP 12847241.2 Issued
NIAID E-253-2011-3-FR-11 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE FR EP 12847241.2 Issued
NIAID E-253-2011-3-DE-10 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE DE EP 12847241.2 Issued
NIAID E-253-2011-3-EP-03 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE EP National Stage 12847241.2 Issued
NIAID E-253-2011-3-ZA-06 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE ZA National Stage 2014/03264 Issued
NIAID E-253-2011-3-RU-08 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE RU National Stage 2014118462 Issued
NIAID E-253-2011-3-CN-02 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE CN National Stage 201280065580.1 Issued
NEI E-115-2010-0-US-10 Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice US National Stage 13/581,884 Abandoned
NIAID E-253-2011-3-PCT-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE PCT PCT COMB PCT/US2012/063958 Expired
NHLBI E-003-2013-0-US-01 Methods For Treating Or Preventing Necrosis US 61/723,496 Abandoned
NIDDK E-064-2004-0-US-26 USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD OF DETERMINING PREDISPOSITION TO SAID TREATMENT US CON 13/669,324 Abandoned
NCATS E-234-2012-0-AR-31 PAK Inhibitors For the Treatment of Fragile X Syndrome AR National Stage 20120104155 Abandoned
NCATS E-234-2012-0-TW-29 PAK Inhibitors For the Treatment of Fragile X Syndrome TW National Stage 101141080 Abandoned
NIAAA E-258-2012-0-US-01 Ketone Bodies To Protect Tissues From Damage By Ionizing Radiation US 61/722,630 Abandoned
NCATS E-234-2012-0-PCT-03 PAK Inhibitors For the Treatment of Fragile X Syndrome PCT PCT PCT/US12/063426 Expired
NCATS E-234-2012-0-CN-08 PAK Inhibitors For the Treatment of Fragile X Syndrome CN National Stage 201280066130.4 Abandoned
NCATS E-234-2012-0-EP-13 PAK Inhibitors For the Treatment of Fragile X Syndrome EP National Stage 12845870.0 Abandoned
NEI E-248-2012-0-US-01 METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT DURING TREATMENT WITH A MEK INHIBITOR US 61/721,810 Abandoned
NCATS E-234-2012-0-CA-07 PAK Inhibitors For the Treatment of Fragile X Syndrome CA National Stage 2854462 Abandoned
NCATS E-234-2012-0-CO-06 PAK Inhibitors For the Treatment of Fragile X Syndrome CO National Stage 14119.699 Abandoned
NCATS E-234-2012-0-TH-24 PAK Inhibitors For the Treatment of Fragile X Syndrome TH National Stage 1401002411 Pending
NCATS E-234-2012-0-UA-25 PAK Inhibitors For the Treatment of Fragile X Syndrome UA National Stage 201406114 Pending
NCATS E-234-2012-0-AU-30 PAK Inhibitors For the Treatment of Fragile X Syndrome AU National Stage 2012327187 Abandoned
NCATS E-234-2012-0-SG-23 PAK Inhibitors For the Treatment of Fragile X Syndrome SG National Stage 11201401996T Abandoned
NCATS E-234-2012-0-MY-20 PAK Inhibitors For the Treatment of Fragile X Syndrome MY National Stage PI 2014001294 Pending
NIDCR E-160-2000-1-US-07 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US CON 13/666,740 8624012 Expired PDF
NIAID E-299-2011-0-PCT-02 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines PCT PCT PCT/US2012/062998 Expired
NCI E-086-2006-0-US-21 Anti-Mart-1 T Cells Receptors And Related Materials And Methods Of Use US DIV 13/667,036 Abandoned
NIAID E-299-2011-0-BR-04 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines BR National Stage 1120120277405 Pending
NCI E-050-2010-0-US-03 METHOD OF SENSITIZING CANCER CELLS TO THE CYTOTOXIC EFFECTS OF DEATH RECEPTOR LIGANDS IN CANCER TREATMENT US National Stage 13/516,514 9238069 Issued PDF
NCI E-224-2011-0-PCT-02 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR PCT PCT PCT/US12/62212 Expired
NIAID E-160-2010-1-US-02 Method of Treating HIV Infection: Inhibition of DNA Dependent Protein Kinase US National Stage 13/643,819 Abandoned